InvestmentPitch Media: Resverlogix Announces First Patient Dosing for Covid19 Clinical Trials


"Resverlogix has partnered with EVERSANA ™, a pioneer of next generation commercial services to the global life sciences industry, to support the rapid commercialization of apabetalone for COVID-19 in Canada and the United States."


SOURCE

Recent Posts

See All